Infection is the second leading cause of death in patients with cancer. Loss of efficacy in
antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing …

Healthcare‐associated infections due to multidrug‐resistant Gram‐negative bacteria (MDR‐
GNB) are a leading cause of morbidity and mortality worldwide. These evidence‐based …

The diagnosis, investigation and particularly management of bronchiectasis has been
largely empirical and the subject of relatively few controlled clinical trials. There are no clear …

Antimicrobial resistance is increasing; however, antimicrobial drug development is slowing.
Now more than ever before, antimicrobial stewardship is of the utmost importance as a way …

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

This document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and …

This paper reports on the consensus conference on the management of intra-abdominal
infections (IAIs) which was held on July 23, 2016, in Dublin, Ireland, as a part of the annual …

Nosocomial infections affect about 30% of patients in intensive-care units and are
associated with substantial morbidity and mortality. Several risk factors have been identified …

While critically ill patients experience a life-threatening illness, they commonly contract
ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely …

Antimicrobial resistance is a global public health crisis. Antimicrobial Stewardship involves
adopting systematic measures to optimize antimicrobial use, decrease unnecessary …